EUVIMEDEUVIMED entdecken
Crossref

Stimuli-Responsive Nanoadjuvant Rejuvenates Robust Immune Responses to Sensitize Cancer Immunotherapy

Ruijie Huang, Peijie Zhou, Bo Chen, Yang Zhu iD, Xiaoyuan Chen iD, Yuanzeng Min iD

ACS Nano · 14.11.2023 · 17 (21) · 21455-21469

DOI: 10.1021/acsnano.3c06233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 28.10.2023. Verfasst von Ruijie Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Science and Technology of China, Hefei 230026, China. Hauptthemen laut MEDLINE: Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: University of Science and Technology of China, Ministry of Education - Singapore, National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCancer VaccinesHumansAnimalsMiceImmunotherapyAntigens, NeoplasmT-LymphocytesImmunityTumor Microenvironment

Stichwörter der Autor:innen

clinical translationimidazoquinolineimmune checkpoint blockade therapynanotherapeutic platformnanovaccine

Substanzen

Antigens, NeoplasmCancer Vaccines

Autor:innen und Institutionen

  • Department of Chemistry, University of Science and Technology of China, Hefei 230026, China.
  • The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.
  • Department of Neurosurgery, Neurosurgery Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
  • Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.

ORCID-Profile: Yang Zhu, Xiaoyuan Chen, Yuanzeng Min

Förderung

  • University of Science and Technology of China
  • Ministry of Education - Singapore
  • National Medical Research Council
  • Fundamental Research Funds for the Central Universities
  • National University of Singapore
  • National Natural Science Foundation of China
  • National Research Foundation

Zitieren

APA

Huang, R., Zhou, P., Chen, B., Zhu, Y., Chen, X., & Min, Y. (2023). Stimuli-Responsive Nanoadjuvant Rejuvenates Robust Immune Responses to Sensitize Cancer Immunotherapy. ACS Nano, 17(21), 21455-21469. https://doi.org/10.1021/acsnano.3c06233

Vancouver

Huang R, Zhou P, Chen B, Zhu Y, Chen X, Min Y. Stimuli-Responsive Nanoadjuvant Rejuvenates Robust Immune Responses to Sensitize Cancer Immunotherapy. ACS Nano. 2023;17(21):21455-21469. doi:10.1021/acsnano.3c06233

BibTeX
@article{Huang2023,
  author = {Huang, Ruijie and Zhou, Peijie and Chen, Bo and Zhu, Yang and Chen, Xiaoyuan and Min, Yuanzeng},
  title = {Stimuli-Responsive Nanoadjuvant Rejuvenates Robust Immune Responses to Sensitize Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {21},
  pages = {21455--21469},
  doi = {10.1021/acsnano.3c06233}
}
Kostenlos starten →